GB9913782D0 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- GB9913782D0 GB9913782D0 GBGB9913782.0A GB9913782A GB9913782D0 GB 9913782 D0 GB9913782 D0 GB 9913782D0 GB 9913782 A GB9913782 A GB 9913782A GB 9913782 D0 GB9913782 D0 GB 9913782D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- novel compounds
- novel
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9913782.0A GB9913782D0 (en) | 1999-06-14 | 1999-06-14 | Novel compounds |
PCT/GB2000/002330 WO2000076488A2 (en) | 1999-06-14 | 2000-06-14 | Use of a ppar agonist for treating type 1 diabetes |
AU55470/00A AU5547000A (en) | 1999-06-14 | 2000-06-14 | Novel treatment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9913782.0A GB9913782D0 (en) | 1999-06-14 | 1999-06-14 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9913782D0 true GB9913782D0 (en) | 1999-08-11 |
Family
ID=10855294
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9913782.0A Ceased GB9913782D0 (en) | 1999-06-14 | 1999-06-14 | Novel compounds |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU5547000A (en) |
GB (1) | GB9913782D0 (en) |
WO (1) | WO2000076488A2 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004500389A (en) * | 2000-03-09 | 2004-01-08 | アベンティス・ファーマ・ドイチユラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | Use of PPAR mediators in therapy |
EP1911462A3 (en) | 2001-01-26 | 2011-11-30 | Schering Corporation | Compositions comprising a sterol absorption inhibitor |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
CN101772513B (en) | 2007-06-04 | 2013-11-13 | 协同医药品公司 | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
EP2328910B1 (en) | 2008-06-04 | 2014-08-06 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
EP3241839B1 (en) | 2008-07-16 | 2019-09-04 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
WO2012027331A1 (en) | 2010-08-27 | 2012-03-01 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
WO2014151206A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
JP2016514670A (en) | 2013-03-15 | 2016-05-23 | シナジー ファーマシューティカルズ インコーポレイテッド | Guanylate cyclase receptor agonists in combination with other drugs |
CA2913737A1 (en) | 2013-06-05 | 2014-12-11 | Synergy Pharmaceuticals, Inc. | Ultra-pure agonists of guanylate cyclase c, method of making and using same |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10199003I1 (en) * | 1987-09-04 | 2003-06-12 | Beecham Group Plc | Substituted thiazolidine ion derivatives |
GB9604242D0 (en) * | 1996-02-28 | 1996-05-01 | Glaxo Wellcome Inc | Chemical compounds |
AU3091197A (en) * | 1996-05-16 | 1997-12-05 | Boehringer Mannheim Gmbh | New process for preparing troglitazone |
WO1997045141A1 (en) * | 1996-05-31 | 1997-12-04 | Sankyo Company, Limited | Remedy for autoimmune diseases |
GB9908647D0 (en) * | 1999-04-15 | 1999-06-09 | Smithkline Beecham Plc | Novel compounds |
-
1999
- 1999-06-14 GB GBGB9913782.0A patent/GB9913782D0/en not_active Ceased
-
2000
- 2000-06-14 AU AU55470/00A patent/AU5547000A/en not_active Abandoned
- 2000-06-14 WO PCT/GB2000/002330 patent/WO2000076488A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
AU5547000A (en) | 2001-01-02 |
WO2000076488A2 (en) | 2000-12-21 |
WO2000076488A3 (en) | 2001-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1140083A4 (en) | Novel compounds | |
GB9902084D0 (en) | Novel compounds | |
GB9913782D0 (en) | Novel compounds | |
GB9902697D0 (en) | Novel compounds | |
EG24063A (en) | Novel compounds | |
GB9901256D0 (en) | Novel compounds | |
GB9902937D0 (en) | Novel compounds | |
GB9902880D0 (en) | Novel compounds | |
GB9902070D0 (en) | Novel compounds | |
GB9902166D0 (en) | Novel compounds | |
GB9902074D0 (en) | Novel compounds | |
GB9900162D0 (en) | Novel compounds | |
GB9900952D0 (en) | Novel compounds | |
GB9900090D0 (en) | Novel compounds | |
GB9902163D0 (en) | Novel compounds | |
GB9901078D0 (en) | Novel compounds | |
GB9901209D0 (en) | Novel compounds | |
GB0009267D0 (en) | Novel compounds | |
GB9901368D0 (en) | Novel compounds | |
GB9901462D0 (en) | Novel compounds | |
GB9901463D0 (en) | Novel compounds | |
GB9902164D0 (en) | Novel compounds | |
GB9901465D0 (en) | Novel compounds | |
GB9902165D0 (en) | Novel compounds | |
GB9902069D0 (en) | Novel compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |